Tarceva (OSI-774)

DRUG2 trials

Sponsors

M.D. Anderson Cancer Center, Dana-Farber Cancer Institute

Conditions

Colorectal CancerLung CancerNeoplasm Metastasis

Phase 2

Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer

TerminatedNCT00063258

M.D. Anderson Cancer CenterLung Cancer

Start: 2003-06-30End: 2008-04-30Updated: 2016-05-09

Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer

CompletedNCT00123851

Dana-Farber Cancer InstituteColorectal Cancer, Neoplasm Metastasis

Start: 2003-03-31End: 2006-08-31Target: 32Updated: 2009-04-28